2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T7769,

Summary Table

Feature	Diabetic Ketoacidosis (DKA)	Hyperosmolar Hyperglycemic State (HHS)
Risk Factors	Type 1 DM (can occur in Type 2); young patients; new-onset diabetes; infection, noncompliance, physiologic stress	Type 2 DM; elderly; nursing home residents; limited water access; infection, stroke, MI
Etiology	Absolute or near-absolute insulin deficiency leading to lipolysis and ketogenesis	Relative insulin deficiency with profound dehydration; enough insulin to prevent ketosis but not hyperglycemia
Patient Presentation	Polyuria, polydipsia, nausea/vomiting, abdominal pain, altered mental status	Profound dehydration, progressive lethargy to coma, focal neurological deficits possible
Classic Physical Exam	Kussmaul respirations, fruity breath odor, dry mucous membranes, tachycardia, diffuse abdominal tenderness	Severe dehydration, hypotension, tachycardia, altered sensorium ranging to coma, no Kussmaul breathing
Key Diagnostic Results	Glucose >250 mg/dL, pH <7.3, bicarb <18, positive serum ketones, elevated anion gap	Glucose >600 mg/dL, serum osmolality >320 mOsm/kg, pH >7.3, bicarb >18, absent or minimal ketones
Management	Aggressive IV fluids, continuous insulin infusion, potassium replacement, monitor anion gap closure	Aggressive IV fluids (priority), continuous insulin infusion (lower rate), potassium replacement
Keywords	"Fruity breath," "Kussmaul breathing," "anion gap metabolic acidosis," "new-onset Type 1," "abdominal pain in a young diabetic"	"Elderly diabetic with altered mental status," "extreme hyperglycemia," "profound dehydration," "serum osmolality >320"

1. Pathophysiology

DKA

DKA results from absolute insulin deficiency combined with a surge in counter-regulatory hormones (glucagon, cortisol, catecholamines, growth hormone). Without insulin, glucose cannot enter cells, triggering the body to perceive a state of starvation despite severe hyperglycemia. The liver responds by ramping up gluconeogenesis and glycogenolysis, worsening the hyperglycemia further.

The critical event in DKA is unopposed lipolysis. Free fatty acids flood the liver and undergo beta-oxidation, producing acetoacetate, beta-hydroxybutyrate, and acetone. These ketone bodies are organic acids that consume bicarbonate, producing a high anion gap metabolic acidosis (HAGMA). The body compensates through respiratory alkalosis, which manifests clinically as Kussmaul respirations, deep and rapid breathing aimed at blowing off $CO_2$ to raise pH. The fruity odor on the breath comes from acetone, a volatile ketone exhaled through the lungs.

Hyperglycemia causes an osmotic diuresis: glucose exceeds the renal threshold (~180 mg/dL), spills into the urine, and drags water and electrolytes with it. This produces polyuria, dehydration, and total body potassium depletion. The abdominal pain seen in DKA, particularly in children, is thought to be related to gastric distension, ileus from electrolyte derangements, and peritoneal irritation from ketoacidemia. This abdominal pain resolves with treatment and should not prompt unnecessary surgical evaluation.

One critical concept: although total body potassium is always depleted in DKA (due to osmotic diuresis and vomiting), the serum potassium may appear normal or even elevated on initial labs. This is because insulin deficiency and acidosis both shift potassium out of cells into the extracellular space. Once you give insulin, potassium rushes back into cells and serum levels can plummet dangerously. This is why potassium must be checked before starting insulin.

HHS

HHS shares the hyperglycemia and dehydration pathway with DKA but diverges at one key branch point: there is enough residual insulin to prevent ketogenesis but not enough to control glucose. Because lipolysis is partially suppressed, patients do not develop significant ketoacidosis. Without the drive of acidosis and nausea/vomiting, patients do not seek medical attention early. This allows hyperglycemia to build insidiously over days to weeks, often reaching glucose levels of 800 to 1200 mg/dL.

The prolonged osmotic diuresis leads to profound volume depletion, often 8 to 10 liters of total body water deficit. The extreme hyperglycemia raises serum osmolality well above 320 mOsm/kg, and this hyperosmolarity is the primary driver of the neurological dysfunction seen in HHS, ranging from confusion to seizures to frank coma. The degree of mental status change correlates directly with the degree of hyperosmolarity, not the glucose level itself.

Corrected sodium is an important concept in both conditions. Hyperglycemia pulls water from the intracellular space into the extracellular space, diluting serum sodium. For every 100 mg/dL increase in glucose above 100, sodium decreases by approximately 1.6 mEq/L (some guidelines use 2.4 mEq/L for glucose >400). The formula:

$$Na_{corrected} = Na_{measured} + 1.6 \times \frac{Glucose - 100}{100}$$

This correction is essential for calculating true effective osmolality, which determines the severity of HHS and guides fluid management.

2. Classification and Clinical Manifestation

DKA Severity Classification

Parameter	Mild	Moderate	Severe
Plasma glucose	>250 mg/dL	>250 mg/dL	>250 mg/dL
Arterial pH	7.25 to 7.30	7.00 to 7.24	<7.00
Serum bicarbonate	15 to 18 mEq/L	10 to <15 mEq/L	<10 mEq/L
Urine ketones	Positive	Positive	Positive
Serum ketones	Positive	Positive	Positive
Anion gap	>10	>12	>12
Mental status	Alert	Alert or drowsy	Stupor or coma

HHS Diagnostic Criteria

Parameter	Threshold
Plasma glucose	>600 mg/dL
Effective serum osmolality	>320 mOsm/kg
Arterial pH	>7.30
Serum bicarbonate	>18 mEq/L
Serum ketones	Absent or trace
Mental status	Ranging from confusion to coma

Clinical Manifestations

System	DKA	HHS
Respiratory	Kussmaul respirations, fruity breath	Normal respiratory pattern
GI	Nausea, vomiting, abdominal pain (can mimic acute abdomen)	Minimal GI symptoms
Neurological	Generally alert unless severe; mental status changes correlate with acidosis severity	Prominent altered sensorium; focal neurological deficits, seizures possible
Cardiovascular	Tachycardia, hypotension from dehydration	Severe hypotension, tachycardia, higher risk of thromboembolic events
Onset	Rapid (hours to 1 to 2 days)	Insidious (days to weeks)
Fluid deficit	3 to 6 liters	8 to 10 liters

Overlap syndromes exist. Approximately one-third of patients present with features of both DKA and HHS. A patient can have glucose >600 with pH <7.3 and positive ketones. Exam vignettes that combine these features are testing whether you recognize that management principles still follow the same algorithm.

3. Diagnostic Workup

Test	Purpose	Expected Findings in DKA	Expected Findings in HHS
Fingerstick glucose (Best Initial Test)	Rapid bedside assessment	>250 mg/dL	>600 mg/dL
Basic metabolic panel	Electrolytes, BUN/Cr, glucose, bicarb	Low bicarb, elevated anion gap, elevated BUN/Cr	Normal bicarb, elevated BUN/Cr (prerenal pattern), very high glucose
Arterial blood gas	Acid-base status	pH <7.3, low $pCO_2$ (respiratory compensation)	pH >7.3
Serum ketones (beta-hydroxybutyrate)	Confirm ketoacidosis	Elevated (beta-hydroxybutyrate >3 mmol/L)	Absent or trace
Serum osmolality	Assess hyperosmolarity	Variable, usually <320	>320 mOsm/kg (diagnostic hallmark)
Urinalysis	Ketones, glucose, signs of UTI as precipitant	Ketonuria, glucosuria	Glucosuria without significant ketonuria
CBC, blood cultures, CXR, UA	Identify precipitating cause	Leukocytosis common even without infection (stress response)	Workup for infection, stroke, MI
Serum potassium	Guide insulin timing	May be normal or high despite total body depletion	Same concern
ECG	Cardiac monitoring, potassium effects, rule out MI as trigger	Look for peaked T waves (hyperkalemia) or flattened T/U waves (hypokalemia)	Same, plus rule out acute coronary event

The best initial test in any patient presenting with polyuria, polydipsia, and altered mental status is a fingerstick glucose. This takes seconds and immediately stratifies you into the hyperglycemic crisis pathway.

Once hyperglycemia is confirmed, the next priority is to distinguish DKA from HHS. This hinges on three values: pH, serum bicarbonate, and serum ketones. A pH below 7.3 with low bicarbonate and an elevated anion gap in the setting of positive ketones confirms DKA. A markedly elevated glucose (>600) with serum osmolality above 320, normal pH, and absent ketones points to HHS.

Beta-hydroxybutyrate is preferred over the urine ketone dipstick. The urine dipstick detects acetoacetate using the nitroprusside reaction, but in DKA the predominant ketone body is beta-hydroxybutyrate. Early in treatment, as beta-hydroxybutyrate converts back to acetoacetate, the urine dipstick may paradoxically become "more positive" even as the patient improves. This is a classic exam trap: do not use urine ketone levels to monitor treatment response. Follow the anion gap and serum beta-hydroxybutyrate instead.

Anion gap calculation is fundamental:

$$Anion\ Gap = Na^+ - (Cl^- + HCO_3^-)$$

Normal anion gap is 8 to 12. In DKA, the anion gap is elevated because ketoacids (unmeasured anions) accumulate. Closure of the anion gap (return to normal) is the marker that ketoacidosis has resolved, not normalization of glucose. Glucose normalizes long before the acidosis clears.

Always check serum potassium before starting insulin. If potassium is below 3.3 mEq/L, hold insulin and replace potassium first. Giving insulin to a hypokalemic patient can precipitate fatal cardiac arrhythmias.

Search for the precipitating cause using the classic mnemonic of the "5 I's": Infection (most common), Insulin noncompliance, Infarction (MI), Intoxication/drugs (steroids, atypical antipsychotics like olanzapine), and Initial presentation (new-onset Type 1 DM presenting as DKA).

4. Management and Treatment

Step	DKA	HHS
1. IV Fluids	0.9% NaCl at 15 to 20 mL/kg/hr for first hour, then adjust based on corrected sodium	0.9% NaCl at 15 to 20 mL/kg/hr for first hour (fluid resuscitation is the top priority)
2. Potassium	If K <3.3: hold insulin, give 20 to 40 mEq/hr IV KCl. If K 3.3 to 5.3: add 20 to 30 mEq to each liter of IV fluid. If K >5.3: hold potassium, recheck in 2 hours	Same protocol
3. Insulin	Regular insulin bolus 0.1 U/kg IV, then continuous drip at 0.1 U/kg/hr (or no bolus and drip at 0.14 U/kg/hr)	Lower threshold for insulin; start at 0.02 to 0.05 U/kg/hr after initial fluid resuscitation
4. Dextrose addition	When glucose reaches 200 mg/dL, switch fluids to D5 half-normal saline and reduce insulin to 0.02 to 0.05 U/kg/hr	When glucose reaches 300 mg/dL, add dextrose to fluids
5. Bicarbonate	Only if pH <6.9 (give 100 mEq NaHCO3 in 400 mL water over 2 hours)	Rarely needed
6. Transition to subQ	When anion gap closes, pH >7.3, bicarb >15, patient is eating: overlap subQ insulin with IV drip for 1 to 2 hours before discontinuing drip	When osmolality normalizes and mental status clears

Step 1: Aggressive Fluid Resuscitation

This is the single most important initial intervention in both DKA and HHS. Patients are profoundly volume-depleted. Start with isotonic saline (0.9% NaCl) at 15 to 20 mL/kg/hour (roughly 1 to 1.5 liters in the first hour). After the initial bolus, subsequent fluid choice depends on the corrected sodium: if corrected sodium is high or normal, switch to 0.45% NaCl at 250 to 500 mL/hr; if corrected sodium is low, continue 0.9% NaCl. In HHS, fluid resuscitation alone can lower glucose by 75 to 100 mg/dL per hour through dilution and restored renal perfusion.

Step 2: Potassium Replacement Before Insulin

This is the single most tested management principle. The decision tree:

Potassium <3.3 mEq/L: This is the critical threshold. Do not give insulin. Replace potassium at 20 to 40 mEq/hr via central line until K is above 3.3, then start insulin. Insulin given in the setting of hypokalemia drives potassium further into cells, risking fatal arrhythmias and respiratory muscle paralysis.
Potassium 3.3 to 5.3 mEq/L: Safe to start insulin. Add 20 to 30 mEq KCl to each liter of IV fluid to maintain levels.
Potassium >5.3 mEq/L: Do not supplement. Recheck every 2 hours. The elevated level is a distributional artifact from acidosis and insulin deficiency; it will fall rapidly with treatment.

Step 3: Insulin Therapy

Use regular insulin as a continuous IV infusion. Two accepted protocols exist: (1) 0.1 U/kg IV bolus followed by 0.1 U/kg/hr drip, or (2) no bolus and start at 0.14 U/kg/hr. The target is a glucose decline of 50 to 75 mg/dL per hour. If glucose is not dropping at this rate, double the infusion. If it drops too fast, reduce the rate.

The critical concept: do not stop the insulin drip just because glucose has normalized. In DKA, insulin is being given to shut off ketogenesis, not merely to lower glucose. Stopping insulin prematurely will cause a rebound in ketoacid production. When glucose reaches 200 mg/dL in DKA (or 300 mg/dL in HHS), add dextrose (D5) to the IV fluids and reduce the insulin rate to 0.02 to 0.05 U/kg/hr. This allows continued insulin delivery to clear the remaining ketoacidosis while preventing hypoglycemia.

Step 4: Bicarbonate

Bicarbonate administration is only indicated when pH is below 6.9. At this level of acidosis, myocardial contractility and catecholamine responsiveness are severely impaired. Give 100 mEq sodium bicarbonate diluted in 400 mL sterile water with 20 mEq KCl infused over 2 hours. If pH is 6.9 to 7.0, some guidelines still recommend consideration, but above 7.0, bicarbonate provides no benefit and may paradoxically worsen intracellular acidosis via $CO_2$ diffusion across cell membranes.

Step 5: Transition to Subcutaneous Insulin

DKA resolution criteria: anion gap has closed (returned to less than or equal to 12), pH >7.3, bicarbonate >15 mEq/L, and the patient is able to eat. At this point, give the first dose of subcutaneous basal insulin (long-acting insulin like glargine) and continue the IV drip for 1 to 2 hours after the subQ dose to allow absorption. Abruptly stopping the drip without overlap will cause a gap in insulin coverage and potential rebound DKA.

Step 6: Monitoring

Check glucose every 1 hour and electrolytes (including potassium and anion gap) every 2 to 4 hours during active management.

5. Differential Diagnosis and Distractors

Differential	Why It Is Similar	Key Discriminator
Alcoholic ketoacidosis (AKA)	Anion gap metabolic acidosis with positive ketones	Glucose is low to normal (not elevated >250); history of chronic alcohol use with recent binge and poor oral intake; typically malnourished
Starvation ketosis	Positive ketones in urine	Mild ketonemia only; glucose is low or normal; no acidosis (pH remains normal); bicarb is preserved
Lactic acidosis	High anion gap metabolic acidosis	Ketones are negative; elevated serum lactate; look for signs of tissue hypoperfusion (sepsis, shock, mesenteric ischemia)
Uremic acidosis (renal failure)	High anion gap metabolic acidosis with altered mental status	Markedly elevated BUN/creatinine; negative ketones; history of chronic kidney disease; electrolyte pattern shows hyperkalemia and hyperphosphatemia from renal failure rather than distributional shifts
Toxic ingestions (methanol, ethylene glycol, salicylates)	High anion gap metabolic acidosis	Osmolar gap is elevated in methanol/ethylene glycol; salicylate levels are diagnostic; specific toxidromes present (visual changes in methanol, oxalate crystals in urine for ethylene glycol, tinnitus and mixed acid-base disorder in salicylates)
Acute pancreatitis	Abdominal pain, nausea/vomiting in a DKA patient	DKA itself causes elevated lipase in up to 15 to 25% of cases without true pancreatitis; the abdominal pain of DKA resolves with correction of acidosis; imaging confirmation required before diagnosing concurrent pancreatitis
Acute surgical abdomen	Severe abdominal pain and vomiting, especially in children with DKA	DKA abdominal pain is diffuse, not localized; resolves with IV fluids and insulin; no peritoneal signs on serial exams; unnecessary laparotomy is a classic trap

6. Traps and High-Yield Pearls

The single most common trap on this topic is the potassium-insulin sequencing error. A vignette will present a classic DKA picture, the labs will show a potassium of 3.1 mEq/L, and the question will ask for the next best step. Students instinctively choose "start insulin drip" because the diagnosis is clearly DKA, but the correct answer is "replace potassium first, then start insulin." The test is evaluating whether you understand that insulin drives potassium intracellularly and that giving insulin to a hypokalemic patient can cause a fatal arrhythmia. If you remember nothing else, remember: potassium below 3.3 means no insulin until repleted.

The second major trap is stopping the insulin drip when glucose normalizes. A vignette will show a DKA patient whose glucose has fallen to 180 mg/dL after several hours of treatment. The question asks for the next step. The wrong answer is "discontinue insulin infusion." The correct answer is "add dextrose to IV fluids and reduce insulin rate." The insulin drip must continue until the anion gap closes, because the purpose of insulin is to halt ketogenesis, not just to lower glucose.

Third, do not confuse the resolution criteria. DKA is resolved when the anion gap normalizes, not when glucose normalizes and not when urine ketones clear. Urine ketones can remain positive for hours after resolution due to the nitroprusside reaction detecting acetoacetate (which accumulates during treatment as beta-hydroxybutyrate is converted).

Fourth, students frequently confuse DKA with HHS based on glucose level alone. A glucose of 900 does not automatically mean HHS. Check the pH, bicarbonate, and ketones. The anion gap, not the glucose, tells you which crisis you are managing. Overlap presentations exist and are commonly tested.

Fifth, watch for the cerebral edema trap in pediatric DKA. In children, overly aggressive fluid resuscitation or too-rapid glucose correction (dropping >100 mg/dL per hour) can precipitate cerebral edema, presenting as headache, altered consciousness, and bradycardia hours into treatment. The treatment is IV mannitol (0.5 to 1 g/kg) or hypertonic saline (3%). This is a favorite exam question in pediatric emergency scenarios.

Finally, for HHS, the key teaching point is that fluid resuscitation is more important than insulin in the initial management. Unlike DKA where insulin is started relatively early, in HHS the primary pathology is dehydration-driven hyperosmolarity. Aggressive IV fluids alone may substantially reduce glucose, and insulin is started at a lower rate and often only after initial volume repletion. The neurological deficits in HHS (hemiparesis, seizures) can mimic stroke and should not trigger a stroke workup before checking a glucose level.

1e:["$","$L2d",null,{"article":{"id":"87421b58-e453-40f6-8f85-5d9dc1ba40c2","title":"Krisis Hiperglikemia (KAD & HHS)","content":"$2e","category":"Endokrin-Metabolik","created_at":"2026-05-17T03:49:13.769204+00:00","status":"published","subcategory":null},"questionCount":7,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]